PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Fortitech, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Fortitech, Inc.'s New Ontario California Facility Nearing Completion - Fortitech, Inc., the world leader in custom nutrient premixes for the food, beverage, and pharmaceutical industry, is well into the renovation and construction of a new plant in Ontario, California
Fortitech, Inc.'s New Ontario California Facility Nearing Completion

 

NewswireToday - /newswire/ - Schenectady, NY, United States, 2007/06/19 - Fortitech, Inc., the world leader in custom nutrient premixes for the food, beverage, and pharmaceutical industry, is well into the renovation and construction of a new plant in Ontario, California.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Scheduled to be fully completed later this summer, the new Ontario facility will be a 53,000 sq/ft, state of the art plant that will increase Fortitech’s overall North American premix production dramatically.

Facts about Fortitech’s New Ontario, California Facility:

• 53,000 sq/ft (approximately 350% larger than current Fontana facility)
• Higher capacity blenders
• Better customer service
• Ability to service the western USA faster and more efficiently
• Projected to produce over 7,000 tons of custom premixes per year
• Expanded botanical premix capabilities
• Will utilize state-of-the-art technology (GMP standards and all other certifications)
• Higher premix certification standards
• Improved Location: Ontario is just 14mi from Fontana, 31mi from Anaheim and 37mi from Los Angeles

“This major investment is part of Fortitech’s ongoing global commitment to strengthening its customer service and client relations efforts, plus ensuring top-notch manufacturing/lab capabilities” said Walt Borisenok, president and CEO of Fortitech. “The new Ontario location will, without question, allow us to better serve the growing demands for custom nutrient premixes and support rapidly growing markets throughout the western United States.

Also underway with Fortitech’s global expansion efforts is the construction of a brand new manufacturing and laboratory facility outside of Kuala Lumpur, Malaysia; the recent relocation of a larger distribution office in Mexico City and the addition of an additional 35,000 square feet of warehouse/manufacturing space at Fortitech’s New York-based headquarter facility.

About Fortitech, Inc.
Founded in 1986, Fortitech, Inc. (fortitech.com) is the world leader in the development of custom nutrient premixes for the food, beverage and pharmaceutical industries, integrating functional ingredients from a comprehensive selection of vitamins, minerals, amino acids, nucleotides and nutraceuticals. Fortitech is ISO 9001:2000 and FPA certified and meets kosher and Halal standards. Headquartered in Schenectady, N.Y., the company has a global network of manufacturing and distribution facilities, throughout Europe, Asia Pacific, South America, Mexico and the United States (New York and California). powered by FortiSource® - the ultimate fortification destination.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Fortitech, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Fortitech, Inc.'s New Ontario California Facility Nearing Completion

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mark Fanion 
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Fortitech, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Fortitech, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)